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Abstract
Synthetic nanoporous materials have numerous potential biological and medical applications that
involve sorting, sensing, isolating and releasing biological molecules. Nanoporous systems
engineered to mimic natural filtration systems are actively being developed for use in smart
implantable drug delivery systems, bioartificial organs, and other novel nano-enabled medical
devices. Recent advances in nanoscience have made it possible to precisely control the
morphology as well as physical and chemical properties of the pores in nanoporous materials that
make them increasingly attractive for regulating and sensing transport at the molecular level. In
this work, an overview of nanoporous membranes for biomedical applications is given. Various in
vivo and in vitro membrane applications, including biosensing, biosorting, immunoisolation and
drug delivery, are presented. Different types of nanoporous materials and their fabrication
techniques are discussed with an emphasis on membranes with ordered pores. Desirable properties
of membranes used in implantable devices, including biocompatibility and antibiofouling
behavior, are discussed. The use of surface modification techniques to improve the function of
nanoporous membranes is reviewed. Despite the extensive research carried out in fabrication,
characterization, and modeling of nanoporous materials, there are still several challenges that must
be overcome in order to create synthetic nanoporous systems that behave similarly to their
biological counterparts.
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Biomedical engineers have recently recognized that medical implants require well-defined
and controlled interfaces. One of the major obstacles preventing the clinical application of
active devices that perform biologically useful functions has been the reduction in function
after implantation due to poor understanding of the implant-tissue interface [1, 2]. It is still
not possible to maintain long-term in vivo functionality of an active medical implant, even
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when the device demonstrates satisfactory in vitro performance for prolonged periods of
time. The external surface of an active implant has to possess properties that are not
comparable with those necessary for hip prostheses and other traditional structural implants.
The biomaterials community over the past fifty years has excelled at creating materials that
are either completely inert (e.g., hip prosthesis) or completely biodegradable (e.g. resorbable
sutures). The new challenge for biomaterials engineering is the development of materials
that minimize cell adhesion, protein deposits, and encapsulation, since these biological
reactions reduce the ability of active medical devices to interact with the biological
environment. Biosensors and drug delivery implants are active medical devices that must be
capable of function during use over the months, years, and possibly decades. These devices
must exhibit functional stability under a wide range of biological conditions. The functional
lifetime of an active medical device will be dramatically increased if biofouling (especially
protein absorption) and inflammation are minimized.
In an effort to meet long-term physical and chemical stability requirements, researchers have
looked for an ideal interface that allows selective molecular exchange between the host
tissue and the implant, while protecting the latter against immune rejection. There are
innumerable examples of nanoporous interfaces performing multiple functions in biological
systems, for example, cell membranes separate the interior of the cell from its environment
and tightly regulate molecular traffic in and out of the cells through nanometer scale protein
pores. To give a specific example, a synthetic membrane around an artificial pancreas would
allow the passage of glucose, oxygen and other small molecules, but exclude the passage of
proteins and other large molecules. Perhaps the likelihood of success in designing
biocompatible membranes with desired functionality will increase if an effort was made to
mimic the function of biological membranes as closely as possible. As we move into the era
of nanomedicine, the development of such smart nanoporous membranes becomes critical
for a variety of implantable medical devices, including controlled as well as signal-
responsive drug delivery [3], immunoisolation devices [4], and microdialysis systems [5].
In addition to potential applications in implantable devices, nanoporous materials because of
their ability to discriminate molecules based on size, shape and interaction, have gained
considerable prominence in the biomedical area in the development of miniaturized devices
for biomolecular analysis [6]. Currently, biomolecules are routinely separated for
bioanalytical purposes using porous gel structures either by gel filtration or by gel
electrophoresis. In response to the push towards more efficient separation techniques
functionalized nanoporous structures with ordered pores are extensively explored to
accomplish sensing, sorting, releasing, and isolating biomolecules in implantable devices in
addition to bioanalytical techniques.
The aim of this review is to present an overview of nanoporous materials highlighting both
diagnostic and therapeutic biomedical applications as well as the key challenges to be
addressed in realizing ideal synthetic membranes discussed above. Porous materials have
long been used in many important industrial applications such as catalysis, membrane
separation, and storage. In the literature, porous materials are often referred to as
nanoporous if the pore size is between 1 – 100 nm [7]. While multiple terminologies have
been used to describe these materials, for the sake of consistency we will use the term
nanoporous to refer to all porous materials with pore size less than 100 nm. Section 1
contains a brief account of various types of nanoporous materials, including track etched
membranes, microfabricated membranes, and nanoporous membranes. In section 2,
biomedical applications of nanoporous materials will be reviewed. In section 3, we will
discuss surface modification techniques to improve biocompatibility and fouling resistance.
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Finally, key scientific challenges and future directions will be discussed in the concluding
remarks.
1. Types of nanoporous membranes
Nanoporous membranes, due to a diverse set of materials, pore geometry and fabrication
techniques, can be broadly classified as follows:
a) Type of material: Nanoporous membranes encompass a wide range of inorganic
(metals, ceramics etc), organic (polymeric) and composite materials. For liquid
phase separation, various types of nanoporpous oxides, typically alumina,
titania, zirconia and silica, have been developed [8]. Recently, inorganic
nanoporous materials with well ordered pores such as anodic alumina and
nanoporous silica have gained considerable attention for use in biomedical
applications. A majority of the commercial filtration and liquid phase separation
applications use polymeric ultra or microfiltration membranes. Some of the
typical polymeric nanoporous materials are Nafion, polycarbonate, polyethylene
terephthalate, polysulfone etc. Another important class is composite membranes.
Membranes containing two different materials have been developed in order to
improve selectivity as well as stability. Such nanoporous materials have been
prepared by combining, for example, a polymer with a ceramic [8].
b) Type of fabrication method: Many different synthesis methods exist to fabricate
nanoporous materials. One of them is the anodization process, in which
nanoporous films are prepared by selective electrochemical leaching of
substances from solids. Nanoporous materials can be made with
microfabrication techniques such as lithography as well as focused ion beam
etching [9]. Two most common routes to nanoporous polymeric films are ion-
track etching and phase separation technique [10, 11]. Another widely used
method is sol-gel process, which is often used to grow multi-component ceramic
nanoporous materials [8].
c) Type of pores (size, shape and order): Porous materials are often distinguished
based on pore size, size distribution, shape and order. Typically, they are
classified as microporous (< 2nm), mesoporous (2–50 nm) and macroporous (>
50 nm) based on size [7]. Porous materials are considered uniform if the size
distribution is narrow as opposed to a wide pore-size distribution. The pores can
be cylindrical, conical, slit-like, or irregular in shape. They can be well ordered
with a vertical alignment as opposed to a random network of tortuous pores.
Table 1 summarizes various nanoporous membranes based on the type of material and the
fabrication technique. Nanoporous materials that are important to biomedical applications
will be summarized, with a special emphasis on materials with ordered pores.
The successful application of nanoporous interfaces in biomedical devices depends on
several critical membrane properties (Fig. 1). First, the ability to fabricate membranes with a
desired pore size and a narrow pore size distribution will enable a precise control over
molecular transport. Second, in many applications a low flow resistance to enable high flux
(characterized by high porosity and low membrane thickness) is desired [12]. Third, an
adequate mechanical strength with respect to transmembrane pressure and sufficient thermal
and chemical stability under a wide range of biological environment are essential for long
term usage. Finally, for in vivo applications, biocompatibility and resistance to biofouling
are vital to prevent immunological response and loss of functionality, respectively.
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At present, the majority of the applications involving biomolecular separation use polymeric
membranes with a random pore matrix. For example, polymer gels (agarose or
polyacrylamide) are routinely used in gel based electrophoresis for size separating DNA,
proteins etc. Another technologically relevant class of polymer membranes is porous
polymer matrices formed by initiating the precipitation of a polymer from solution. The
solution precipitates into polymer rich domains that encompass voids to form a filter
structure. The structure of pores in these materials is random, often characterized by tortuous
pore paths and with broad pore size distributions. These polymer matrices can inexpensively
separate biomolecules in large quantities by size (e.g., for sample preconcentration).
However, a well ordered pore structure is desired for controlled molecular transport and
separation. In addition, a narrow pore size distribution with no tail to long pore sizes is a
prerequisite to discriminating molecules with a small difference in size. While it is a
challenge to fabricate thin, robust nanoporous membranes with very precise pore sizes and
geometry, advances in nanofabrication methods have opened up exciting new avenues to
overcome the limitations of conventional porous materials.
2.1 Polymeric membranes
Porous organic materials play an important role in biomedical applications and are under
extensive investigation [10, 11, 13]. By far the most common method to fabricate polymeric
porous membranes with relatively ordered pore arrays as well as pores close to cylindrical
geometry is ion track technology. Filtration membranes are routinely manufactured from
various polymers including polycarbonate and polyethylene terephthalate. The process
involves irradiating a thin polymeric film with accelerated heavy ions, which leave so-called
ion tracks. These ion tracks can then be enlarged to pores by chemical etching with an
appropriate reagent that preferentially attacks the damaged track zone. Cylindrical or conical
pores are produced with diameters in the range of 10 nm to micrometers [10, 11, 13, 14].
These membranes have their limitations because the preparation of pores with diameters in
the lower nanometer range is not possible.
Another very interesting technique to produce membranes is via the phase separation
micromolding (PSμM) [11]. Phase separation micromolding (PSμM) is a replication
technology based on phase separation, in which a polymer solution cast into a mold is
solidified by phase separation and, during the solidification, assimilates the profile of the
mold. The new developments in organic nanoporous structures in terms of structural and
chemical properties and their applications are reviewed in detail in the papers by Ulbricht
[11] as well as by Langley and Hulliger [15].
2.2 Microfabricated membranes
Recently, micro- and nanofabrication technology has emerged as an attractive way to make
ordered and cylindrical arrays of nanopores on silicon and silicon nitride surfaces.
Considerable effort has been devoted to developing porous silicon and silicon nitride
membranes using lithography. In an attempt to overcome the problems such as broad pore
size distributions, poor mechanical properties and biochemical instability associated with the
conventional polymeric membranes, Desai et al. [16] proposed micromachined nanoporous
biocapsules with well-controlled pore-sizes as small as 7 nm to provide immunoisolating
microenvironments for encapsulated cells. These silicon nanoporous membranes are
biocompatible, allow for the free exchange of nutrients, waste products and secreted
therapeutic proteins and provide immunoisolation to transplanted cells. In addition,
microfabricated porous silicon membranes have been applied to an implantable artificial
pancreas [17] and oral drug delivery systems [18].
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Membranes with very regular pore structures, pore sizes down to 100 nm, and thickness
values of 1–5 μm are often termed “nanosieves”; these structures can be achieved through
photolithography and focused ion beam etching. For example, Tong et al. have fabricated an
array of very uniform cylindrical nanopores with a pore diameter as small as 25 nm in an
ultrathin micromachined silicon nitride membrane using focused ion beam (FIB) etching
[19].
2.3 Anodized membranes
One of the extensively investigated nanoporous materials using electrochemical-etching
technique is anodic aluminum oxide (AAO) membranes. Porous alumina membranes
obtained with common anodic processes usually have a honeycomb-like pore structure with
short distance ordering [20–22]. The pore geometry and morphology can be controlled by
the conditions during the anodization processes. In recent years, a great success has been
made in the preparation of AAO membranes with highly ordered nanochannel arrays.
Conventional anodizing of aluminum could produce ordered nanochannel array with a
limited range of pore-sizes through self-organized process [20, 23 – 25]. The degree of the
self-organization in the hole-array depends on the anode voltage as well as the acid used in
fabrication. However, the most effective method for developing ordered porous anodic
alumina with large dimension is the pretexture process, in which a shallow ordered pattern is
first produced on the surface of an aluminum wafer, and the ordered channel structures are
obtained by the following anodization process [23]. Using this method, Masuda and co-
workers produced porous anodic alumina with almost defect-free, ordered channel arrays
[26]. The size of the membrane was on the order of millimeters, with a channel density of
1010 cm−2 and an aspect ratio over 150. The smallest channel diameter was about 70 nm
with 100 nm intervals. Fig. 2 shows the channel-array architectures of the anodic alumina
with different intervals obtained by Masuda et al. [26]. The anodization of aluminum was
conducted in oxalic acid. Further investigation has indicated that the channel interval can be
modified by controlling the pretextured-pattern interval or the applied voltage [27].
Recently, Lee et al. [28] have used a hard anodization process that enables fast fabrication of
AAO membranes with pore sizes down to 40 nm making them ideal for size sorting a wide
range of molecular sizes.
AAO membranes have been explored for use in diffusion controlled filtration systems.
Kipke and Schmid [29] have demonstrated the suitability of alumina membranes for size
sorting by studying the diffusion of crystal violet molecules. In particular, they showed that
the diffusion of crystal violet molecules encapsulated inside micelles is determined by the
pore size whereas the diffusion of uncoated molecules showed no pore size dependence. In a
similar work, Gong et al. [30] have conducted molecular release experiments using
nanoporous AAO capsules and demonstrated that the biocapsules successfully prevented
diffusion of molecules larger than a cutoff size.
In addition to anodized alumina, electrochemical etching has been widely used to develop
nanoporous semiconductors. Silicon was the first semiconductor material used to fabricate
nanoporous structures with electrochemical-etching technique [31, 32]. More recently,
nanoporous semiconductors have been developed with electrochemical etching of, for
example, germanium [33, 34].
2.4 Ordered nanoporous semiconductors
Ordered and patterned silicon porous structures have been studied most extensively,
encouraged by the applications such as MEMS and biomedical devices. Unlike anodized
alumina, and other semiconductors, self-organized pore is difficult to be realized on silicon
[31]. The processes of patterned nanoporous silicon often require the use of lithography,
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oxidization, and Si3N4 deposition processes in a clean room environment. Létant and co-
worker prepared pores on pre-patterned n-type silicon wafers using the backside
illumination; these materials were developed for selective bio-organism capture [35].
3. Biomedical applications of nanoporous materials
Many promising biomedical applications for nanoporous materials have been discovered
and several are currently being explored. In implantable devices the membrane would
function as a semipermeable compartment that holds the implant or drug while allowing
passage of desired molecules in a controlled way. Nanoporous membranes are also suitable
for a wide variety of biomolecular analysis applications. Possible in vitro applications
include diagnosis and protein separation. Enormous research efforts in the past decade have
been applied to automate biological analyses and to reduce sample consumption and cost.
The efforts have led to the development of many microfabricated devices performing
separation, mixing, reaction, detection, or preconcentration. In particular, extraction of
analytes from complex samples has been achieved using variations in diffusivity and
selective transport through membranes. There has been a great push towards the micro total
analysis system (μTAS) or lab-on-a-chip concept [36]. In this section, a brief overview of
biomedical applications involving nanoporous membranes is presented. While the
applications are classified based on the functionality of the membrane, there is clearly some
overlap between them. These applications are summarized with a schematic diagram in Fig.
3.
3.1 Separation and sorting of biomolecules
Separation and sorting is used for isolation and purification of molecules from various
biological feed streams and is important in many fields including pharmaceutical industry,
food industry, and biotechnology. Many techniques, including size exclusion
chromatography and gel electrophoresis of biopolymers, are currently used in separation
science [36, 37]. Biomolecular separation in more ordered pores has recently been examined
for various applications. In the kidney application, the synthetic nanoporous membrane acts
as a support for kidney cells and as a blood filter that retains serum proteins while allowing
smaller waste substances out [38].
The flow of materials through nanopores can also be externally regulated. For example,
Martin and coworkers [39] have fabricated a membrane that consists of an array of
cylindrical gold nanotubules with pore radius less than 1 nm. They demonstrated that by
switching charge on the tubules from positive to negative, ions of opposite charge could be
rejected, allowing for voltage gating of oppositely charged molecules.
3.2 Biosensing
Sensory systems use a variety of membrane bound protein pores to detect molecules and
facilitate cells to respond to stimuli. Such biosensing is also important in many technological
areas including pharmaceutical industry, medical diagnosis and detection of hazardous
biomolecules. In a majority of these applications the biosensing device combines a
biological component with a physiochemical detection component to detect analytes in
biological feed streams. For example, amperometric sensors utilize an immobilized enzyme
for the conversion of the target analytes in a biological system into electrochemically
detectable products. It is one of the most widely used detection methods for the
determination of blood glucose. Glucose oxidase immobilized in porous nanocrystalline
TiO2 film is shown to be capable of sensing blood glucose [40]. Similarly, cholesterol
biosensors have been developed that rely sensing on immobilized cholesterol oxidase
enzymes inside ZnO nanoporous thin films [41].
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Also worth mentioning are the amperometric-type enzymeless nanoporous systems. For
example, recently a glucose sensing system based on nanoporous platinum electrode
embedded in a microfluidic chip comprised of a microfluidic transport channel network and
a miniaturized electrochemical cell has been demonstrated [42]. Bohn and co-workers have
proposed exploiting an array of electrically switchable nanocapillary membranes to perform
sequential sensing and analytic operations in μTAS devices [6]. Another type of biosensor is
a nanoporous material that analyzes one molecule at a time [43]. A brief discussion of these
important materials is provided in the following subsection.
3.3 Single molecular analysis
Nanoporous supports have gained prominence in probing biomacromolecules (DNA, RNA,
and proteins) one by one for single-molecule analysis. It is now well established that by
measuring the frequency, magnitude and duration of blockage in ion-current of an
electrolyte when biomolecules are drawn through nanopores embedded in insulating
membranes, it is possible to access information on the concentration, structure, size and
sequence of , for example, single and double stranded DNA or RNA [44]. This technique
has been applied in detecting biomolecules by using engineered membrane-bound receptors
such as α-hemolysin (α-HL) protein pores embedded in a lipid membrane [45]. Much of the
early research in single molecule analysis used lipid membranes incorporated inside micron
sized apertures in polymeric films such as Teflon. One of the drawbacks of the polymeric
supports with micron-sized pores is that the lipid membranes tend to rupture after a brief
period of usage demanding techniques to improve the durability in order to be useful in
practical applications. Nanoporous membranes have the potential to support protein pores
for single molecule analysis [43].
The range of sensing applications of lipid-bound nanopores is limited by the architecture of
the protein pores. Synthetic nanopores have been explored recently in an effort to expand the
functionality of single molecule detectors. Synthetic nanopores using a variety of materials,
such as glass, polymers and solid state membranes have been demonstrated to be useful for
sensing single-stranded and double-stranded DNA, ions, macromolecules, and proteins.
Synthetic nanopores fabricated with nanoscale control over pore size and pore surface
chemistry would allow regulating analyte-surface interactions and thereby provide means to
impart desired functionality to the sensor. Arrays of these sensor platforms with sensitivity
for multiple analytes can be incorporated in microfluidic devices to create lab-on-a-chip
technology [46].
3.4 Immunoisolation
Immunoisolation refers to protecting implanted cells or drug release systems from an
immune reaction. It is usually accomplished by encapsulation using a nanoporous
semipermeable membrane. The use of nanoporous membranes serves to isolate the
transplanted cells from the body's immune system. These pores are large enough to allow
small molecules such as oxygen, glucose, and insulin to pass, but are small enough to
impede the passage of much larger immune system molecules such as immunoglobulin. For
example, in the artificial pancreas, insulin secreting pancreatic cells are encapsulated inside
an immunoisolating device and a semipermeable membrane acts as an interface between the
cells and the body. Desai et al. have explored using nanoporous silicon interfaces prepared
by microfabrication techniques in implantable artificial pancreas to treat diabetes [47]. It is
important for the nanoporous membrane to be biocompatible and biofouling-resistant for
many in vivo functions.
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The development of in vivo delivery systems to enable supply of drugs locally where they
are needed in a controlled manner is actively sought after. The purpose of controlled
delivery systems is to administer drugs in a chosen way for more effective therapy and to
eliminate the possibility of improper dosing. Nanoporous membranes with well-controlled
pore size, porosity and membrane thickness offer an attractive route for making capsules
that may be used for provide controlled release of pharmacologic agents [48]. For example,
nanoporous materials are researched for use in drug eluting stents to treat coronary artery
disease [17]. Recently, nanoporous inorganic membranes have been tested for sustained
release of ophthalmic drugs to treat conditions related to the eye [3]. When coupled to bio-
sensors, smart drug delivery systems that respond to physiological conditions could be
developed.
4. Surface modifications to improve membrane properties
When biomedical implants come in contact with physiological environments, primarily three
types of reactions limit the long term usage. These are (i) biofouling, (ii) immune reaction as
determined by biocompatibility and (iii) degradation and loss of implant material due to
corrosion, dissolution or leaching. Several different approaches are being explored to
address these issues such that the future medical implants interact with the host in a
controlled and a predictable manner.
Biofouling is the accumulation of cells, proteins, and other materials from the biological
environment on a medical device surface in a way that diminishes or prevents medical
device function. It is caused by adsorptive and adhesive interactions of small molecules,
proteins, and cells on the surface. The biofouling process starts immediately upon contact of
a synthetic material with the body. The adsorbed proteins prevent diffusion of small
molecules to and from an active medical device. Another problem is tissue encapsulation
which is characterized by fibroblast proliferation, collagen synthesis, blood vessel
proliferation, and other cellular processes. These events lead to the formation of a vascular
connective tissue capsule, which retards the transport of low-molecular weight molecules
(e.g., glucose) due to increased diffusion path tortuosity and steric hindrance.
Poor biocompatibility of medical device packaging can also lead to device failures. The
biocompatibility of an implantable device is dictated by the inflammatory response that
occurs after device implantation. Wound healing consists of several stages, including
hemostasis, inflammation, repair, and scar formation. During device implantation,
connective tissue cells and epithelial cells are destroyed and the basement membrane is
disrupted. This injury initiates the inflammatory response responsible for wound healing.
Soon the injured region contains clotted blood. This fibrin clots attract neutrophils within
one day after injury, these inflammatory cells affect the device function by their simple
presence, as they consume nutrients and release proteolytic enzymes and free radicals within
the vicinity of the implant. By day 3, macrophages and granulation tissue are common
features. By day 5, neovascularization is observed at the wound site. Epithelium migrates
and collagen fibrils begin to bridge tears in the implant site. At one week, inflammatory
features have essentially ceased, although there is still connective tissue proliferation.
Finally, by the end of the first month, a mature scar capsule is completed within the
epithelial layer. The biocompatibility of the sensor surface material will influence the
characteristics of each stage in this process. The inflammatory tissue response limits active
device functionality. For example, a thick, avascular, and fibrous implant scar capsule leads
to reduced analyte diffusion and uptake, resulting in a diminished sensor response.
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Several investigators have examined the use of coatings and other modified surfaces in order
to reduce the biofouling of sensors. A good review on this topic can be found in reference
[1]. Hydrogels were one of the first materials used to mitigate biofouling of active medical
devices. The most commonly used hydrogels are the cross-linked polymers of either
poly(hydroxyethyl methacrylate) (PHEMA) or poly(ethylene glycol) (PEG). Coatings of
these polymers are flexible, polar, uncharged and water swellable. These materials produce a
hydrophilic interface between the solid surface and aqueous bulk, thereby masking the
surface. Both PHEMA and PEG are appealing coatings for sensors because water-soluble
analytes can diffuse through the water-swollen polymer layer. The cross-link density of the
gel controls the amount of analyte diffusion.
Several problems have been encountered in applying hydrogels to the device surface: (1)
hydrogels exhibit poor adhesion to substrates; (2) hydrogels have poor mechanical stability
and are unable to withstand the forces of implantation; (3) the monomer, solvent and cross-
linking agent may have detrimental effects on the biological components of the biosensor;
and (4) hydrogels may serve to limit analyte diffusion into the sensor. Hydrogel coatings are
not a viable solution to the biofouling problem.
Another strategy for optimizing the active medical surface is to cover it with a coating that
mimics the body [49 – 51]. The surface should ideally act like a cell membrane, selectively
and specifically binding certain molecules while resisting undesirable, non-specific
interactions. Major research efforts have been undertaken to characterize phospholipid,
phospholipid-containing, or phospholipid-like biomaterials. Unfortunately, phospholipid
membranes are fragile and thus difficult to deposit; hence, most attempts have been aimed at
developing phospholipid-modified polymers. Phospholipid-modified polymer coatings
tested in vivo showed significant reductions in platelet adhesion, platelet activation, and
fibrinogen adsorption. Ultimately, these materials represent a promising, method to prevent
biofouling over relatively short periods of time.
Nafion is a perfluorosulfonic acid polymer that has been studied for use as a coating for
several active medical devices. Nafion is a chemically inert, anionic polymer with both
hydrophobic and hydrophilic properties. Nafion films applied at a thickness of 1–2 μm
promote a low amount of adsorption of molecules from solutions. Unfortunately, these
coatings are chemically stable only for a few weeks; cracking, flaking, protein adhesion, and
calcium deposition are frequent problems.
A surfactant (“surface active agent”) is a molecule that seeks the interface between two
phases [52]. Surfactant molecules possess both hydrophobic and hydrophilic character.
Surfactants are usually lipids with polar (e.g.,anionic, cationic, or uncharged) head groups
attached to hydrocarbon tails. Surfaces that have been adsorbed with pluronic® surfactants
(PEO-PPO-PEO triblock copolymers) possess resistance to protein adsorption and cell
adhesion. Many membranes used in electrochemical sensors contain these surfactant
plasticizing molecules. Unfortunately, the surfactants continually diffuse to the surface and
out of the membrane until they are depleted. Consequently, these surfactants need leaching
antifouling agents, such as calcium chelating plasticizers that limit Factor X activation (an
enzyme in the coagulation cascade), in order to continuously renew the sensor surface.
However, Lindner et al. recently demonstrated that plasticizers leaching from implanted
sensor membranes can cause tissue inflammation. As such, the lifetime of a surfactant-
coated device is seriously limited [53].
Regrettably, none of the biosensor packaging techniques described above entirely eliminates
biofouling. Experiments have shown these surface treatments undergo mineralization in the
biological environment; these processes result in cracking and altered device permeability.
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The inflammatory process described above is not eliminated, it is shifted from seconds or
minutes post-implantation to tens of minutes or days post-implantation.
There are solutions to many of these problems on the horizon. For example, chemical
grafting of PEG chains has attracted much attention as a way to develop nonfouling
interfaces. PEG grafted surfaces have demonstrated a low protein, cell and bacterial
adhesion due to its favorable interaction with water. The grafted PEG chains form a polymer
brush layer and thus exclude other molecules due to repulsive interaction and hence resist
protein adsorption [54]. Further, there is evidence that PEG coating can also improve
biocompatibility of the implants. For example, in vivo tests have demonstrated that while
implantation of AAO capsules into the peritoneal cavity of rats induces a transient
inflammatory response, poly(ethylene glycol) coatings are useful in minimizing the host
response to the material [55].
Diamond-like carbon thin films are another suitable material for implantable biosensors. The
term diamond-like carbon is used to describe amorphous carbon that contains sp3 hybridized
carbon atoms. In a recent study, Narayan et al. demonstrated that diamondlike carbon-coated
nanoporous alumina membranes remained free from fibrin or platelet aggregation after
exposure to human platelet rich plasma [56]. Figure 4 shows that no fibrin networks or
platelet aggregation were observed on the surface of the diamond-like carbon-coated
nanoporous membrane (100 nm pore size) after exposure to human platelet rich plasma.
Only a few small, widely scattered sodium chloride crystals were observed on the film
surface. On the other hand, uncoated membranes exhibited significant protein adsorption
and pore fouling. The clotting process has been attributed to a charge transfer theory first
proposed by Srinivasan et al., in which an exchange of electrons between blood proteins and
the surface of a material initiates the release of fibrinopeptides that bring about thrombosis
[57]. The charge transfer rate during platelet rich plasma-material interaction is a function of
the time constant of the material. The time constant obtained for diamond-like carbon is
higher than those obtained for thrombogenic metal-containing materials. As a result, the
diamondl-ike carbon coatings allow a lower amount of charge transfer. Studies have shown
that platelet adhesion occurs less often on diamond-like carbon surfaces than on titanium,
titanium nitride, and stainless steel surfaces [58–60]. Jones et al. have suggested that the low
surface energy values (40–44 mN m−1) and large contact angle values (75–80° for water)
exhibited by diamond-like carbon limit protein fouling [61].
The biological properties of uncoated nanoporous alumina membranes as well as
nanoporous alumina membranes coated with gold, silicon, and diamond-like carbon thin
films were examined using MTT viability assay. Silicon (Si), gold (Au), diamond-like
carbon (DLC) coatings were deposited on nanoporous alumina membranes using ultraviolet
(wavelength = 248 nm) pulsed laser deposition, which is a physical vapor deposition
process. Figure 5 depicts a comparison of MTT viability for gold-coated, silicon-coated,
diamond-like carbon-coated, and uncoated nanoporous alumina membranes (control), which
shows a significant decrease in human epidermal keratinocyte (HEK) viability with the
addition of gold-coated membranes or silicon-coated membranes in comparison to diamond-
like carbon coated membranes or uncoated alumina (Al) membranes. However, materials
such as gold are considered to have a minimal effect on cells [62].
Coating such materials might also improve chemical stability and leaching resistance of
nanoporous membranes under physiological conditions. Perhaps a more efficient method to
modify nanoporous membranes is by atomic layer deposition (ALD). ALD is a thin film
growth technique that utilizes alternating, self-limiting chemical reactions between gaseous
precursor molecules and a surface to deposit material in an atomic layer-by-layer fashion
[63]. Saturation of the individual reactions ensures that all surfaces of a substrate are coated
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with exactly the same thickness, even for surfaces that are deeply embedded within a porous
material. Consequently, ALD can apply precise layers onto surfaces with extremely high
aspect ratio features such as the nanopores in membranes and thus allowing for conformal
coating [64]. Thus the upshot of the technique is that it leaves no unexposed area unlike in
line-of-sight coating techniques which is critical when the bulk of the membrane is to be
shielded from the harsh biological fluids. A wide variety of materials can be deposited using
ALD including oxides, nitrides, and metals. There is evidence that ALD coating of AAO
with Pt and subsequent functionalization with PEG improves resistance to leaching and
reduces fouling [12]. Besides the potential to impart desired surface chemistry, this
technique provides a conformal coating of nanoporous membranes to achieve a very precise
pore size control, shrinking down their diameters to below ten nanometers with a narrow
distribution. For example, tailor-made compositions and pore sizes have been prepared by
depositing thin films on AAO membranes using ALD [65].
With the general nature of the medical device and the biological environment of the
implant's location in mind we have to address the biocompatibility of the interface to
minimize biofouling, chemical degradation and leaching as well as inflammatory response
[66, 67]. The choice of an ideal surface coating will depend on the problem at hand. It is also
worth pointing out that biofouling and leaching can be problems in in vitro applications as
well.
Conclusion
Nanoporous materials are crucial to many biomedical applications such as immunoisolation
devices, dialysis, smart as well as targeted drug delivery systems, bioanalytical devices and
biosensors. Some of the key properties that these membranes are required to possess are a
pore size of a few tens of a nanometer or less, a narrow pore size distribution to ensure
higher selectivity, and a high porosity and low thickness to enable high flux, mechanical and
chemical stability. Existing commercial membranes offer inexpensive means to separate
bioanalytical applications such as large-scale preconcentration. On the other hand,
development of truly nanoscale devices calls for more controlled pore architecture and the
ability to sort and dispense molecules very precisely. The effort to find suitable nanoporous
interfaces for the diverse biomedical applications will rely on an interdisciplinary approach
involving materials science, chemistry, biology and engineering. As discussed in this paper,
advanced nanofabrication methods have enhanced our abilities to fabricate well-ordered
monodisperse nanopores in ultrathin membranes. Another promising possibility of
nanofabrication is the prospect of integrating nanoporous membranes in lab-on-a-chip
microfluidic systems for medical diagnostics.
In addition to control over pore geometry, biocompatibility and biofouling are central issues
when membranes are used as interfaces in implantable devices. Many challenges lie in
engineering biocompatible and nonfouling nanoporous supports for in vivo drug delivery
applications. Surface modification by coating nanoporous membranes with inorganic as well
as organic materials is currently being explored. While techniques such as modification with
grafted polymers and self-assembled polymers have given promising results during in vitro
testing, in vivo testing will be conducted in the future.
Looking into the future, the next generation nanoporous materials can be envisioned with
multiple functionalities such as size screening, responsive flow regulation, dynamic pore
sizing using external controls etc. Several approaches as described in this paper are currently
being explored in research laboratories to impart stimuli-responsive gating ability to
nanoporous membranes [12]. An example for such a smart membrane is pore surface
modification with responsive polymers that undergo a conformational transition in response
to stimuli such as pH [68, 69], temperature [70] and ion concentration [71]. A significant
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challenge is to construct composite nanoporous membranes that respond to multiple stimuli.
Such novel systems can be used in nano/micro scale chips for programmable drug delivery
and biomolecular analysis.
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A schematic diagram of key membrane characteristics that affect the performance.
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SEM image of ordered porous structures of alumina. The intervals of 100 nm (a), 150 nm
(b) and 200 nm (c). Reused with permission from Hideki Masuda, Applied Physics Letters,
71, 2770 (1997). Copyright 1997, American Institute of Physics.
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Biological applications of nanoporous materials.
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Scanning electron micrograph of anodized diamond-like carbon-coated alumina membrane
exposed to platelet rich plasma. The pulsed laser deposition method was used for the
coating. The surface contains sodium chloride crystals; however, the pores remain free of
fouling. Reprinted with permission from R. Narayan et al., Journal of Nanoscience and
Nanotechnology, 7, 1486 (2007) Copyright @ American Scientific Publishers, http://
www.aspbs.com.
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Twenty-four hour MTT viability assays conducted in human epidermal keratinocytes for
uncoated (Al), gold-coated (Au), silicon-coated (Si), and diamond-like-carbon (DLC)-coated
nanoporous alumina membranes. Si, Au, and DLC coatings were deposited on nanoporous
alumina membranes using ultraviolet (wavelength = 248 nm) pulsed laser deposition.
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